Group
FGFR targeting TKI
The data below refer to patients treated with FGFR targeting TKI as the sole drug class,
excluding any concurrent use of drugs from other groups.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.
Erdafitinib
No data
Futibatinib
No data
Infigratinib
No data
Pemigatinib
No data